Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Coherus Biosciences, Inc. (CHRS)  
$2.27 0.10 (4.61%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,625,000
Market Cap: 187.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.59 - $8.14
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 223,100 223,100 223,100
Total Sell Value $0 $449,770 $449,770 $449,770
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 312
  Page 2 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wahlstrom Mats Director   –       •      –    2022-02-28 4 A $2.08 $62,501 D/D 29,994 40,000     -
   Wahlstrom Mats Director   –       •      –    2022-02-25 4 A $11.64 $116,433 D/D 10,006 10,006     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2022-01-11 4 D $14.36 $51,452 D/D (3,583) 107,421     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2022-01-10 4 D $14.30 $59,345 D/D (4,150) 111,004     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2022-01-04 4 A $0.00 $0 D/D 40,000 115,154     -
   Lanfear Dennis M President & CEO   •       •      –    2022-01-04 4 A $0.00 $0 D/D 86,250 579,508     -
   Stilwell Mcdavid Chief Financial Officer   •       –      –    2022-01-04 4 A $0.00 $0 D/D 40,000 73,138     -
   Stilwell Mcdavid Chief Financial Officer   •       –      –    2021-10-15 4 S $16.80 $58,919 D/D (3,507) 31,611 31%     
   Healy James Director   –       •      –    2021-09-29 4 S $16.12 $4,611,545 I/I (286,076) 0 24%     
   Healy James Director   –       •      –    2021-09-28 4 S $17.17 $829,809 I/I (48,329) 286,076 27%     
   Healy James Director   –       •      –    2021-09-27 4 S $18.06 $1,808,709 I/I (100,150) 334,405 34%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-07-06 4 A $0.00 $0 D/D 50,000 124,790     -
   Stilwell Mcdavid Chief Financial Officer   •       –      –    2021-06-09 4 B $13.42 $49,668 D/D 3,700 35,118 2.74 26%     
   Lanfear Dennis M President & CEO   •       •      –    2021-06-08 4 S $13.56 $421,229 D/D (31,054) 493,258 -29%     
   Lanfear Dennis M President & CEO   •       •      –    2021-06-08 4 OE $0.42 $12,943 D/D 31,054 524,312     -
   Lanfear Dennis M President & CEO   •       •      –    2021-06-06 4 OE $0.42 $125,040 D/D 300,000 493,258     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-04-28 4 A $0.00 $0 D/D 20,000 73,402     -
   Stilwell Mcdavid Chief Financial Officer   •       –      –    2021-04-28 4 A $0.00 $0 D/D 20,000 30,000     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2021-04-28 4 A $0.00 $0 D/D 20,000 73,386     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2021-03-09 4 S $16.25 $1,856,263 D/D (114,240) 53,386 19%     
   Vexler Vladimir Chief Scientific Officer   •       –      –    2021-03-09 4 OE $2.08 $820,665 D/D 102,480 167,626     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-03-05 4 S $15.46 $412,065 D/D (26,649) 53,402 17%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-03-05 4 OE $9.30 $188,902 D/D 20,312 80,051     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-02-17 4 AS $17.45 $43,418 D/D (2,488) 59,739 -16%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-02-17 4 OE $2.50 $6,221 D/D 2,488 62,227     -
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us